Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Nab Paclitero 100 mg Injection
Manufacturer/Marketed By : Hetero Healthcare Ltd
$57.34 $47.73
Sidmex Inovia offers bulk export supply of Nab Paclitero 100 mg Injection (Albumin bound paclitaxel 100 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and...
Albumin bound paclitaxel 100 mg
Active Pharmaceutical Ingredient
Nab Paclitero 100 mg Injection
$57.34
$47.73
Sidmex Inovia offers bulk export supply of Nab Paclitero 100 mg Injection (Albumin bound paclitaxel 100 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Nab Mitotax 100 mg Injection
Nab Paclitero 100 mg Injection is a targeted microtubule inhibitor that plays a crucial role in the treatment of various advanced cancers, including metastatic breast cancer in patients who have not responded to prior combination chemotherapy or have experienced a relapse within six months of receiving adjuvant therapy. This medication is often utilized in conjunction with carboplatin as a first-line option for individuals with locally advanced or metastatic non-small cell lung cancer who are ineligible for curative surgical interventions or radiation. Additionally, Nab Paclitero is prescribed alongside gemcitabine to provide an effective first-line treatment for metastatic pancreatic cancer. It is essential to be aware of potential side effects, such as neutropenia, which can increase the risk of infections, and to monitor for allergic reactions during administration. This injection exemplifies a specialized approach to cancer care, focusing on disrupting the growth of cancer cells while aiming to minimize harm to healthy tissues. Patients considering Nab Paclitero should discuss their overall health and treatment goals with their healthcare provider to ensure the best possible outcomes. With its targeted action, Nab Paclitero represents a significant advancement in the fight against challenging cancer types.
Active Pharmaceutical Ingredient
Uses
• Nab paclitero 100 mg injection is utilized in the treatment of metastatic breast cancer, a condition where cancer cells have spread beyond the breast to other areas such as the bones, liver, or lungs. This medication targets and helps manage the growth of cancerous cells, improving patient outcomes. It is often administered to patients who have not responded to other treatments. The effectiveness of Nab paclitero in this context underscores its importance in comprehensive cancer care.
• Non-small cell lung cancer (NSCLC) is another condition treated with Nab paclitero 100 mg injection. This type of lung cancer originates in lung tissues and can metastasize to various body parts. Patients experiencing symptoms like persistent cough, chest pain, or shortness of breath may benefit from this treatment. Nab paclitero helps to inhibit cancer cell proliferation, offering a therapeutic option for those facing NSCLC.
• In the case of ovarian cancer, Nab paclitero 100 mg injection serves as a vital treatment option. This cancer often goes undetected in its early stages due to vague symptoms, making effective treatment crucial once diagnosed. The injection aids in managing the disease by targeting cancerous cells in the ovaries. By using Nab paclitero, healthcare providers can help improve the quality of life for women diagnosed with this challenging condition.
• Nab paclitero 100 mg injection is also indicated for the treatment of pancreatic adenocarcinoma, a cancer that arises from the pancreas and can be asymptomatic in early stages. Patients may present with late-stage symptoms such as abdominal pain or jaundice. The use of Nab paclitero in this setting focuses on controlling tumor growth and alleviating symptoms. This medication represents a significant component of the treatment strategy for individuals facing this aggressive form of cancer.
Benefits
Nab Paclitero 100 mg Injection is an anticancer medicine that is used to treat many types of cancer, which include breast cancer, lung cancer, ovarian cancer, and pancreatic cancer.it's known to be efficient in treating different types of cancer either alone or in a mixture with other chemotherapy medications or radiation therapy. Nab Paclitero 100 mg interfering with the division of cancer cells, kills or stops the growth of cancer cells and prevents the multiplication of cancer cells and relieves the symptoms of breast cancer and stomach cancer. Anti-cancer Drug Nab Paclitero can improve overall survival and disease-free survival in patients with HER2-positive breast cancer when used in combination with other cancer treatments.
Side Effects
Like all medications, Nab Paclitero Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Hair loss
• Peripheral neuropathy
• Abnormal ECG
• Low blood count
• Nausea
• Vomiting
• Diarrhoea
• Loss of appetite
• Arthralgia ( joint pain)
• Myalgia (muscle pain)
• Mouth sores
• Headache
Common Side Effects
• Irregular Heartbeats ( Tachycardia/Bradycardia)
• Vision changes
• Bleeding
• Dizziness
• Vision changes
How To Use
Anti-cancer Drug Nab Paclitero is an intravenous infusion, administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of the Nab Paclitero 100 mg Injection will be determined by the patient's clinical condition, age, medical history, type of cancer and other factors. It is important to note that this Nab Paclitero 100 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Nab Paclitero 100 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Nab Paclitero 100 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Nab Paclitero 100 mg Injection is safe to use in patients with kidney disease. No dose adjustment of Nab Paclitero 100 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Nab Paclitero 100 mg Injection. Nab Paclitero 100 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Nab Paclitero 100 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Nab Paclitero 100 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Nab Paclitero 100 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Albumin Bound Paclitaxel Injection 100 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Nab Paclitero 100 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Nab Paclitero 100 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Nab Paclitero 100 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Albumin Bound Paclitaxel Injection 100 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.